Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001.

Poirier JT, Reddy PS, Idamakanti N, Li SS, Stump KL, Burroughs KD, Hallenbeck PL, Rudin CM.

J Gen Virol. 2012 Dec;93(Pt 12):2606-13. doi: 10.1099/vir.0.046011-0. Epub 2012 Sep 12.

PMID:
22971818
2.

Structural features of the Seneca Valley virus internal ribosome entry site (IRES) element: a picornavirus with a pestivirus-like IRES.

Willcocks MM, Locker N, Gomwalk Z, Royall E, Bakhshesh M, Belsham GJ, Idamakanti N, Burroughs KD, Reddy PS, Hallenbeck PL, Roberts LO.

J Virol. 2011 May;85(9):4452-61. doi: 10.1128/JVI.01107-10. Epub 2011 Feb 16.

3.

Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features.

Rudin CM, Poirier JT, Senzer NN, Stephenson J Jr, Loesch D, Burroughs KD, Reddy PS, Hann CL, Hallenbeck PL.

Clin Cancer Res. 2011 Feb 15;17(4):888-95. doi: 10.1158/1078-0432.CCR-10-1706. Epub 2011 Feb 8.

4.

Discovery of WAY-260022, a Potent and Selective Inhibitor of the Norepinephrine Transporter.

Gavrin LK, Mahaney PE, Jenkins D, Nogle LM, Mugford CA, Huselton C, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Alfinito P, Ho DM, Deecher DC, Trybulski EJ.

ACS Med Chem Lett. 2010 Mar 25;1(3):91-5. doi: 10.1021/ml100009p. eCollection 2010 Jun 10.

5.

Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.

Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ.

Bioorg Med Chem Lett. 2009 Oct 1;19(19):5807-10. doi: 10.1016/j.bmcl.2009.07.050. Epub 2009 Aug 25.

PMID:
19713106
6.

Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.

Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC.

J Med Chem. 2008 Jul 10;51(13):4038-49. doi: 10.1021/jm8002262. Epub 2008 Jun 17.

PMID:
18557608
7.

Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers.

Reddy PS, Burroughs KD, Hales LM, Ganesh S, Jones BH, Idamakanti N, Hay C, Li SS, Skele KL, Vasko AJ, Yang J, Watkins DN, Rudin CM, Hallenbeck PL.

J Natl Cancer Inst. 2007 Nov 7;99(21):1623-33. Epub 2007 Oct 30.

8.

Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL.

Burroughs KD, Kayda DB, Sakhuja K, Hudson Y, Jakubczak J, Bristol JA, Ennist D, Hallenbeck P, Kaleko M, Connelly S.

Cancer Gene Ther. 2004 Feb;11(2):92-102.

PMID:
14730331
10.

Dysregulation of IGF-I signaling in uterine leiomyoma.

Burroughs KD, Howe SR, Okubo Y, Fuchs-Young R, LeRoith D, Walker CL.

J Endocrinol. 2002 Jan;172(1):83-93.

PMID:
11786376
11.
12.

Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma.

Gamage SD, Bischoff ED, Burroughs KD, Lamph WW, Gottardis MM, Walker CL, Fuchs-Young R.

J Pharmacol Exp Ther. 2000 Nov;295(2):677-81.

PMID:
11046105
13.

Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma.

Walker CL, Burroughs KD, Davis B, Sowell K, Everitt JI, Fuchs-Young R.

J Soc Gynecol Investig. 2000 Jul-Aug;7(4):249-56.

PMID:
10964025
14.

Insulin-like growth factor-I: a key regulator of human cancer risk?

Burroughs KD, Dunn SE, Barrett JC, Taylor JA.

J Natl Cancer Inst. 1999 Apr 7;91(7):579-81. No abstract available.

PMID:
10203270
15.

Regulation of apoptosis in uterine leiomyomata.

Burroughs KD, Kiguchi K, Howe SR, Fuchs-Young R, Trono D, Barrett JC, Walker C.

Endocrinology. 1997 Jul;138(7):3056-64. Erratum in: Endocrinology 1997 Sep;138(9):3786.

PMID:
9202252

Supplemental Content

Loading ...
Support Center